$28.5
6.3%
Price vs. AI Score (Last 150 days)
Data gathered: December 11
Data gathered: December 11
Data Bits
| Data Bits | Value / Change | Benchmark |
|---|---|---|
| Job Posts | N/A | N/A |
| Sentiment | N/A | N/A |
| Webpage traffic | N/A | N/A |
| Employee Rating | N/A | N/A |
| Linkedin Employees | N/A | N/A |
| Patents | N/A | N/A |
| 4chan Mentions | N/A | N/A |
| Stocktwits Mentions | N/A | N/A |
| Stocktwits Subscribers | N/A | N/A |
| Twitter Followers | N/A | N/A |
| Instagram Followers | N/A | N/A |
| News Mentions | N/A | N/A |
| Reddit Mentions | N/A | N/A |
| Business outlook | N/A | N/A |
In the news
 |
CRISPR Continuous to Innovate! Exploring the Future of Cell & Gene Therapy, Industry Leaders Converge at the 2024 GenScript Biotech Global ForumDecember 6 - InvestorsObserver |
Genome Editing Market projected to reach USD 24.0 Billion by 2030, growing at a CAGR of 18.0% during the forecast period of 2023-2030 - claims by MarketDigits in its recent studyDecember 6 - GlobeNewswire |
|
Gene Editing Market Size Worth USD 35.84 Billion in 2032 | Emergen ResearchNovember 30 - GlobeNewswire |
|
 |
CRISPR Gene Editing: Intellia Vs. Crispr TherapeuticsNovember 28 - Seeking Alpha |
 |
2 Dirt-Cheap Stocks That Could Rocket Higher in a Bull MarketNovember 27 - Yahoo |
 |
CRISPR-Cas9 Gene Editing Is On The Cusp Of Something BigNovember 24 - SeekingAlpha |
About Intellia Therapeutics
Intellia Therapeutics is a clinical-stage biotechnology company focused on developing novel, potentially curative therapeutics leveraging CRISPR-based technologies.
| Price | $28.5 |
| Target Price | Sign up |
| Market Cap | $2.6B |
| Dividend Yield | 0 |
| Industry | Biotechnology |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
|---|---|---|---|---|---|
| Q3 '23 | 13M | 29M | -16M | -122M | -131M |
| Q2 '23 | 16M | 31M | -14M | -124M | -132M |
| Q1 '23 | 20M | 27M | -7.1M | -103M | -112M |
| Q4 '22 | 22M | 24M | -1.6M | -113M | -105M |
| Q3 '22 | 21M | 22M | -1.6M | -113M | -96M |
Insider Transactions
| Bhanji Muna filed to sell 11,996 shares at $23.9. November 2 '23 |
| Bhanji Muna filed to sell 12,261 shares at $42.3. August 2 '23 |
| Bhanji Muna filed to sell 12,526 shares at $39.3. July 10 '23 |
| Clark Eliana filed to sell 45,146 shares at $40.5. July 6 '23 |
| Clark Eliana filed to sell 45,146 shares at $45. June 22 '23 |
Read more about Intellia Therapeutics and their earnings, price prediction, job posts, sentiment, webpage traffic, employee rating, linkedin employees, patents, 4chan mentions, stocktwits mentions, stocktwits subscribers, twitter followers, instagram followers, news mentions, reddit mentions, business outlook.